Implementing clinical pathways to enable early diagnosis and treatment of wild‐type transthyretin amyloid cardiomyopathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Implementing clinical pathways to enable early diagnosis and treatment of wild‐type transthyretin amyloid cardiomyopathy

Published:2023-05-30 Issue:6 Volume:25 Page:854-856
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Muller Steven A.¹²³,Oerlemans Marish I.F.J.¹³^ORCID

Affiliation:

1. Department of Cardiology University Medical Center Utrecht Utrecht The Netherlands

2. Netherlands Heart Institute Utrecht The Netherlands

3. Member of the European Reference Network for rare, low prevalence and complex diseases of the Heart (ERN GUARD‐Heart) Amsterdam The Netherlands

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2890

Reference16 articles.

1. Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System

2. Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta‐analysis

3. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

4. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

5. Cardiac amyloidosis: the need for early diagnosis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis;Therapeutic Advances in Cardiovascular Disease;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP